Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
Decitabine
Medication labelDecitabine for Injection is indicated for treatment of adult patients with myelodysplastic syndromes (MDS) including previously treated and…
Why this: Advisory · dailymed-prescription
Decitabine for Injection is indicated for treatment of adult patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System groups.
- generic_name
- decitabine
- product_names
- Decitabine
- ndc
- 71288-119, 71288-119-20
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en